These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 37790551)
21. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients. Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291 [TBL] [Abstract][Full Text] [Related]
22. An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters. Deng S; Liu Y; Tam RC; Chen P; Zhang AJ; Mok BW; Long T; Kukic A; Zhou R; Xu H; Song W; Chan JF; To KK; Chen Z; Yuen KY; Wang P; Chen H Nat Commun; 2023 Apr; 14(1):2081. PubMed ID: 37045873 [TBL] [Abstract][Full Text] [Related]
23. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Fernández-Castañeda A; Lu P; Geraghty AC; Song E; Lee MH; Wood J; O'Dea MR; Dutton S; Shamardani K; Nwangwu K; Mancusi R; Yalçın B; Taylor KR; Acosta-Alvarez L; Malacon K; Keough MB; Ni L; Woo PJ; Contreras-Esquivel D; Toland AMS; Gehlhausen JR; Klein J; Takahashi T; Silva J; Israelow B; Lucas C; Mao T; Peña-Hernández MA; Tabachnikova A; Homer RJ; Tabacof L; Tosto-Mancuso J; Breyman E; Kontorovich A; McCarthy D; Quezado M; Vogel H; Hefti MM; Perl DP; Liddelow S; Folkerth R; Putrino D; Nath A; Iwasaki A; Monje M Cell; 2022 Jul; 185(14):2452-2468.e16. PubMed ID: 35768006 [TBL] [Abstract][Full Text] [Related]
24. Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination. Hulscher N; Procter BC; Wynn C; McCullough PA Cureus; 2023 Nov; 15(11):e49204. PubMed ID: 38024037 [TBL] [Abstract][Full Text] [Related]
25. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology. Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A; Sano K; Saito S; Shiwa-Sudo N; Nagata N; Tamura K; Suzuki R; Hasegawa H; Suzuki T Vaccine; 2022 Sep; 40(41):5892-5903. PubMed ID: 36064667 [TBL] [Abstract][Full Text] [Related]
26. Higher pro-inflammatory cytokines IL-6 and IFN-γ are associated with anti-SARS-CoV-2 spike protein-specific seroconversion in renal allograft recipients. Yadav B; Prasad N; Kushwaha RS; Patel MR; Bhadauria D; Kaul A Transpl Infect Dis; 2023 Oct; 25(5):e14133. PubMed ID: 37605477 [TBL] [Abstract][Full Text] [Related]
27. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status. Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR Elife; 2021 Oct; 10():. PubMed ID: 34636722 [TBL] [Abstract][Full Text] [Related]
29. Defending against SARS-CoV-2: The T cell perspective. Almendro-Vázquez P; Laguna-Goya R; Paz-Artal E Front Immunol; 2023; 14():1107803. PubMed ID: 36776863 [TBL] [Abstract][Full Text] [Related]
37. Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern. Ruhl L; Kühne JF; Beushausen K; Keil J; Christoph S; Sauer J; Falk CS Front Immunol; 2023; 14():1120010. PubMed ID: 37033958 [TBL] [Abstract][Full Text] [Related]
38. Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis. Ruiz MJ; Siracusano G; Cottignies-Calamarte A; Tudor D; Real F; Zhu A; Pastori C; Capron C; Rosenberg AR; Temperton N; Cantoni D; Liao H; Ternette N; Moine P; Godement M; Geri G; Chiche JD; Annane D; Cramer Bordé E; Lopalco L; Bomsel M Front Immunol; 2022; 13():842468. PubMed ID: 36248831 [TBL] [Abstract][Full Text] [Related]
39. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency. Quinti I; Locatelli F; Carsetti R Front Immunol; 2021; 12():815404. PubMed ID: 35126372 [TBL] [Abstract][Full Text] [Related]
40. Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines. Boley PA; Lee CM; Schrock J; Yadav KK; Patil V; Suresh R; Lu S; Feng MM; Hanson J; Channappanavar R; Kenney SP; Renukaradhya GJ J Nanobiotechnology; 2023 Feb; 21(1):60. PubMed ID: 36814238 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]